|
J. Biol. Chem., Vol. 264, Issue 20, 11658-11662, Jul, 1989
Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites
ML Schwartzman, JR Falck, P Yadagiri and B Escalante
Department of Pharmacology, New York Medical College, Valhalla 10595.
We recently demonstrated that 20-hydroxyeicosatetraenoic acid (20-HETE)
constricts rat aortic rings. The contractile response was partially
dependent on the presence of endothelium and was abolished by pretreatment
of the rings with either indomethacin or the endoperoxide/thromboxane
receptor antagonist, SQ29548. Addition of GSH or SnCl2 to the organ bath
diminished the contractile response of 20- HETE, whereas preincubation of
the rings with a thromboxane synthase inhibitor did not affect the 20-HETE
induced contractions. Short time incubation (2 min) of 20-HETE with ram
seminal vesicle microsomes in the presence of p-hydroxymercurybenzoate
yielded metabolites which migrated similarly on thin layer chromatography
to the known arachidonate endoperoxides prostaglandin (PG) G2 and PGH2 and
possess vasoconstrictory properties. The vasoconstriction was
dose-dependent with a half-life of approximately 6.3 +/- 0.6 min. Addition
of SQ29548 to the aortic ring bath 1 min after metabolite elicited
vasoconstriction produced immediate relaxation. Furthermore, pretreatment
of the rings with SQ29548 totally abolished the contraction. SnCl2
reduction of the metabolites produced in incubation of rat seminal vesicles
with 20-HETE and p-hydroxymercurybenzoate resulted in a single radioactive
peak which was further identified by gas chromatography/mass spectrometry
as 20-hydroxy-PGF2 alpha. The inhibitory effect of SQ29548, the appearance
of labile metabolites with a half-life of approximately 6 min and the
production of 20-hydroxy- PGF2 alpha by SnCl2 reduction clearly indicate
that the vasoconstrictor metabolites of 20-HETE are the labile
endoperoxides of 20-HETE, 20- hydroxy-PGG2, and 20-hydroxy-PGH2.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Antoun, S. Goulitquer, Y. Amet, Y. Dreano, J.-P. Salaun, L. Corcos, and E. Plee-Gautier
CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis
J. Lipid Res.,
October 1, 2008;
49(10):
2135 - 2141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Fang, F. M. Faraci, T. L. Kaduce, S. Harmon, M. L. Modrick, S. Hu, S. A. Moore, J. R. Falck, N. L. Weintraub, and A. A. Spector
20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase
Am J Physiol Heart Circ Physiol,
November 1, 2006;
291(5):
H2301 - H2307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Goodman, P. N. Chander, R. Rezzani, M. L. Schwartzman, R. F. Regan, L. Rodella, S. Turkseven, E. A. Lianos, P. A. Dennery, and N. G. Abraham
Heme Oxygenase-2 Deficiency Contributes to Diabetes-Mediated Increase in Superoxide Anion and Renal Dysfunction
J. Am. Soc. Nephrol.,
April 1, 2006;
17(4):
1073 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Oyekan
Differential Effects of 20-Hydroxyeicosatetraenoic Acid on Intrarenal Blood Flow in the Rat
J. Pharmacol. Exp. Ther.,
June 1, 2005;
313(3):
1289 - 1295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kawada, K. Dennehy, G. Solis, P. Modlinger, R. Hamel, J. T. Kawada, S. Aslam, T. Moriyama, E. Imai, W. J. Welch, et al.
TP receptors regulate renal hemodynamics during angiotensin II slow pressor response
Am J Physiol Renal Physiol,
October 1, 2004;
287(4):
F753 - F759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Little, M. Kurkela, J. Sonka, S. Jantti, R. Ketola, S. Bratton, M. Finel, and A. Radominska-Pandya
Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases
J. Lipid Res.,
September 1, 2004;
45(9):
1694 - 1703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fuloria, D. M. Eckman, D. A. Leach, and J. L. Aschner
20-Hydroxyeicosatetraenoic acid is a vasoconstrictor in the newborn piglet pulmonary microcirculation
Am J Physiol Lung Cell Mol Physiol,
August 1, 2004;
287(2):
L360 - L365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Kaduce, X. Fang, S. D. Harmon, C. L. Oltman, K. C. Dellsperger, L. M. Teesch, V. R. Gopal, J. R. Falck, W. B. Campbell, N. L. Weintraub, et al.
20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells
J. Biol. Chem.,
January 23, 2004;
279(4):
2648 - 2656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Cheng, J. C. McGiff, and M. A. Carroll
Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase
Am J Physiol Renal Physiol,
March 1, 2003;
284(3):
F474 - F479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Randriamboavonjy, R. Busse, and I. Fleming
20-HETE-Induced Contraction of Small Coronary Arteries Depends on the Activation of Rho-Kinase
Hypertension,
March 1, 2003;
41(3):
801 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Newman, T. Watanabe, and B. D. Hammock
The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS
J. Lipid Res.,
September 1, 2002;
43(9):
1563 - 1578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Wang, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman
Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2002;
282(2):
R383 - R389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev,
January 1, 2002;
82(1):
131 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Tsao, S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot, J. A. Goldstein, and D. C. Zeldin
Identification and Localization of Five CYP2Cs in Murine Extrahepatic Tissues and Their Metabolism of Arachidonic Acid to Regio- and Stereoselective Products
J. Pharmacol. Exp. Ther.,
October 1, 2001;
299(1):
39 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bautista, A. Sanchez, J. Hernandez, A. Oyekan, and B. Escalante
Angiotensin II Type AT2 Receptor mRNA Expression and Renal Vasodilatation Are Increased in Renal Failure
Hypertension,
September 1, 2001;
38(3):
669 - 673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Hercule and A. O. Oyekan
Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2000;
279(6):
R2132 - R2141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Hercule and A. O. Oyekan
Cytochrome P450 omega /omega -1 Hydroxylase-Derived Eicosanoids Contribute to EndothelinA and EndothelinB Receptor-Mediated Vasoconstriction to Endothelin-1 in the Rat Preglomerular Arteriole
J. Pharmacol. Exp. Ther.,
March 1, 2000;
292(3):
1153 - 1160.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. J. M. Kerkhof, E. N. T. P. Bakker, and P. Sipkema
Role of cytochrome P-450 4A in oxygen sensing and NO production in rat cremaster resistance arteries
Am J Physiol Heart Circ Physiol,
October 1, 1999;
277(4):
H1546 - H1552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. McGiff and J. Quilley
20-HETE and the kidney: resolution of old problems and new beginnings
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 1999;
277(3):
R607 - R623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Davis and M. A. Hill
Signaling Mechanisms Underlying the Vascular Myogenic Response
Physiol Rev,
April 1, 1999;
79(2):
387 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Pratt, J. R. Falck, K. M. Reddy, J. B. Kurian, and W. B. Campbell
20-HETE Relaxes Bovine Coronary Arteries Through the Release of Prostacyclin
Hypertension,
January 1, 1998;
31(1):
237 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Askari, C. P. Bell-Quilley, D. Fulton, J. Quilley, and J. C. McGiff
Analysis of Eicosanoid Mediation of the Renal Functional Effects of Hyperchloremia,
J. Pharmacol. Exp. Ther.,
July 1, 1997;
282(1):
101 - 107.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Arima, K. Omata, S. Ito, K. Tsunoda, and K. Abe
20-HETE Requires Increased Vascular Tone to Constrict Rabbit Afferent Arterioles
Hypertension,
March 1, 1996;
27(3):
781 - 785.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1989 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|